Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. [PDF]
Murray SJ +8 more
europepmc +1 more source
A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes. [PDF]
Swier VJ +11 more
europepmc +1 more source
Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease. [PDF]
Mitchell NL +12 more
europepmc +1 more source
Acidified drinking water improves motor function, prevents tremors and changes disease trajectory in Cln2R207X mice, a model of late infantile Batten disease. [PDF]
Kovács AD +2 more
europepmc +1 more source
Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease. [PDF]
De BP +14 more
europepmc +1 more source
The Batten disease protein CLN8 is a stereospecific acyltransferase in bis(monoacylglycero)phosphate biosynthesis. [PDF]
Sheokand PK +23 more
europepmc +1 more source
Batten disease protein CLN8 enables a non-canonical phospholipid synthesis pathway. [PDF]
Breithofer J +17 more
europepmc +1 more source
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten disease. [PDF]
Scotto Rosato A +29 more
europepmc +1 more source
Special edition: The NCLs/Batten disease [PDF]
Rahim, AA, Russell, C, Mole, SE
openaire +3 more sources

